US5354768A
(en)
*
|
1988-07-26 |
1994-10-11 |
Sankyo Company, Limited |
Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
|
US6277969B1
(en)
*
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
US5356897A
(en)
*
|
1991-09-09 |
1994-10-18 |
Fujisawa Pharmaceutical Co., Ltd. |
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
|
GB9303993D0
(en)
*
|
1993-02-26 |
1993-04-14 |
Fujisawa Pharmaceutical Co |
New heterocyclic derivatives
|
TW256831B
(hu)
*
|
1993-04-22 |
1995-09-11 |
Senju Pharma Co |
|
EP0707585A1
(en)
*
|
1993-07-06 |
1996-04-24 |
Pfizer Inc. |
Bicyclic tetrahydro pyrazolopyridines
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
US6228871B1
(en)
|
1995-07-10 |
2001-05-08 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
ATE244219T1
(de)
|
1996-04-25 |
2003-07-15 |
Nissan Chemical Ind Ltd |
Ethylenderivate und pestizide
|
FR2750048B1
(fr)
*
|
1996-06-21 |
1998-08-14 |
Oreal |
Compositions de teinture des fibres keratiniques contenant des derives pyrazolo-(1, 5-a)-pyrimidine, procede de teinture, nouveaux derives pyrazolo-(1, 5-a)-pyrimidine et leur procede de preparation
|
BR9710352A
(pt)
*
|
1996-07-11 |
1999-08-17 |
Pfizer |
Compostos piridilpirrole
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
HU229024B1
(en)
*
|
1996-07-24 |
2013-07-29 |
Bristol Myers Squibb Pharma Co |
Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
|
IL127871A0
(en)
*
|
1996-07-24 |
1999-10-28 |
Du Pont Pharm Co |
Azolo triazines and pyrimidines
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
BR9809451A
(pt)
*
|
1997-05-22 |
2000-06-20 |
Searle & Co |
Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38.
|
US6087381A
(en)
|
1997-05-22 |
2000-07-11 |
G. D. Searle & Company |
Pyrazole derivatives as p38 kinase inhibitors
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
US6087496A
(en)
|
1998-05-22 |
2000-07-11 |
G. D. Searle & Co. |
Substituted pyrazoles suitable as p38 kinase inhibitors
|
US6235741B1
(en)
*
|
1997-05-30 |
2001-05-22 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
EP1473292A1
(en)
*
|
1997-11-03 |
2004-11-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
AU1367599A
(en)
*
|
1997-11-03 |
1999-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
US6380203B1
(en)
*
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
JP2002533412A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー.ディー.サール エルエルシー |
心臓血管に適用するための回腸胆汁酸輸送阻害剤およびコレステリルエステル転送タンパク質阻害剤の組み合わせ
|
ES2203239T3
(es)
|
1998-12-23 |
2004-04-01 |
G.D. Searle Llc |
Combinaciones de inhibidores de la proteina de transferencia de ester de colesterilo y de agentes secuestrantes de acidos biliares para indicaciones cardiovasculares.
|
WO2000038722A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
|
JP2002533414A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー.ディー.サール エルエルシー |
心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ
|
CN1342090A
(zh)
|
1998-12-23 |
2002-03-27 |
G·D·瑟尔有限公司 |
适用于心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合
|
JP2002533408A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー.ディー.サール エルエルシー |
心臓血管に適用するためのコレステリルエステル転送タンパク質阻害剤およびニコチン酸誘導体の組み合わせ
|
DE69908645T2
(de)
|
1998-12-23 |
2004-05-13 |
G.D. Searle Llc, Chicago |
Kombinationen von cholesteryl ester transfer protein inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
|
WO2000059907A2
(en)
|
1999-04-06 |
2000-10-12 |
Du Pont Pharmaceuticals Company |
Pyrazolotriazines as crf antagonists
|
AU4203500A
(en)
|
1999-04-06 |
2000-10-23 |
Du Pont Pharmaceuticals Company |
Pyrazolopyrimidines as crf antagonists
|
JP2003531103A
(ja)
*
|
1999-08-12 |
2003-10-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
c−JUNN−末端キナーゼ(JNK)および他のタンパク質キナーゼの阻害剤
|
AU2006203676B2
(en)
*
|
1999-08-13 |
2010-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-JUN N-Terminal Kinases (JNK) and Other Protein Kinases
|
US6472416B1
(en)
|
1999-08-27 |
2002-10-29 |
Abbott Laboratories |
Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
|
CA2379421A1
(en)
*
|
1999-08-27 |
2001-03-08 |
Abbott Laboratories |
Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
|
AU6729900A
(en)
*
|
1999-08-31 |
2001-03-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Organ preservatives
|
HUP0202678A3
(en)
*
|
1999-09-30 |
2004-06-28 |
Pfizer |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines, pharmaceutical compositions containing them and their use
|
US6794544B2
(en)
|
2000-03-10 |
2004-09-21 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
US6630476B2
(en)
|
2000-07-07 |
2003-10-07 |
Bristol-Myers Squibb Pharma Company |
Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
|
DE10153344A1
(de)
*
|
2001-10-29 |
2003-05-15 |
Gruenenthal Gmbh |
Verwendung von substituierten Pyrazolopyrimidinen als Liganden von Nucleosid-Transport-Proteinen und/oder von Purinorezeptoren
|
UA76461C2
(en)
*
|
2001-05-24 |
2006-08-15 |
Lilly Co Eli |
Pyrrazole derivatives as pharmaceutical agents, use thereof, a pharmaceutical composition on their basis
|
JPWO2003004497A1
(ja)
*
|
2001-07-05 |
2004-10-28 |
住友製薬株式会社 |
新規複素環化合物
|
CA2464685A1
(en)
|
2001-11-02 |
2003-05-15 |
G.D. Searle Llc |
Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
|
WO2003053976A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Biovitrum Ab |
PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR
|
JP2005521653A
(ja)
|
2002-01-17 |
2005-07-21 |
ファルマシア コーポレイション |
先端ナトリウム同時依存性胆汁酸輸送(asbt)およびタウロコール酸塩取込みの阻害剤としての新規アルキル/アリールヒドロキシまたはケトチエピン化合物
|
AU2003228770A1
(en)
*
|
2002-05-10 |
2003-11-11 |
Smithkline Beecham Corporation |
Substituted pyrazolopyrimidines
|
CZ293015B6
(cs)
*
|
2002-10-25 |
2004-01-14 |
Léčiva, A.S. |
Způsob výroby N-ethyl-N-[3-(3-methyl-pyrazolo[1,5-a]pyrimidin-7-yl)-fenyl]-acetamidu (zaleplonu)
|
AU2003298611A1
(en)
*
|
2002-11-21 |
2004-06-18 |
Eli Lilly And Company |
Mixed lineage kinase modulators
|
UA80571C2
(en)
*
|
2002-11-22 |
2007-10-10 |
Lilly Co Eli |
Quinolinyl-pyrrolopyrazoles
|
WO2004110454A1
(ja)
*
|
2003-06-13 |
2004-12-23 |
Ishihara Sangyo Kaisha, Ltd. |
アデノシンA2a受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
|
DE10332487A1
(de)
*
|
2003-07-16 |
2005-02-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
|
US7511065B2
(en)
|
2003-11-12 |
2009-03-31 |
Eli Lilly And Company |
Mixed lineage kinase modulators
|
EP2583678A3
(en)
|
2004-06-24 |
2013-11-13 |
Novartis Vaccines and Diagnostics, Inc. |
Small molecule immunopotentiators and assays for their detection
|
TW200639163A
(en)
*
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
US7608635B2
(en)
*
|
2005-08-12 |
2009-10-27 |
Synta Pharmaceuticals Corp. |
Pyrazole compounds that modulate HSP90 activity
|
JP5066516B2
(ja)
*
|
2005-09-01 |
2012-11-07 |
アステラス製薬株式会社 |
疼痛の治療に用いられるピリダジノン誘導体
|
WO2007129195A2
(en)
*
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
AU2007267843B2
(en)
|
2006-05-25 |
2011-10-13 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
EP2203453A1
(en)
*
|
2007-09-20 |
2010-07-07 |
Wyeth a Corporation of the State of Delaware |
Pyrazolo[5, 1-c] [1,2,4]triazines, methods for preparation and use thereof
|
PL2217600T3
(pl)
|
2007-12-12 |
2013-04-30 |
Du Pont |
Grzybobójcze pirazole bicykliczne
|
WO2010096115A1
(en)
*
|
2008-10-29 |
2010-08-26 |
Apath, Llc |
Compounds, compositions and methods for control of hepatitis c viral infections
|
ES2540867T3
(es)
*
|
2010-02-26 |
2015-07-14 |
Mitsubishi Tanabe Pharma Corporation |
Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
|
US9205086B2
(en)
|
2010-04-19 |
2015-12-08 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
|
EP2402345A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazole fused bicyclic compounds
|
EP2402339A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
EP2402344A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazole fused bicyclic compounds
|
AU2012320581B2
(en)
|
2011-10-06 |
2017-03-30 |
Bayer Intellectual Property Gmbh |
Heterocyclylpyri (mi) dinylpyrazole as fungicidals
|
CA2853806C
(en)
|
2011-11-02 |
2020-07-14 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with platinum-containing agents
|
AU2012332421A1
(en)
|
2011-11-02 |
2014-06-05 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of Hsp90 inhibitors with topoisomerase I inhibitors
|
WO2013074594A1
(en)
|
2011-11-14 |
2013-05-23 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with braf inhibitors
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
MX363680B
(es)
|
2013-03-15 |
2019-03-29 |
Chromocell Corp |
Compuestos moduladores del canal de sodio (nav1. 7) y sus usos para el tratamiento del dolor neuropatico, nociceptivo o inflamatorio.
|
WO2015035062A1
(en)
*
|
2013-09-05 |
2015-03-12 |
Genentech, Inc. |
Antiproliferative compounds
|
JP6445565B2
(ja)
|
2013-09-10 |
2018-12-26 |
クロモセル コーポレイション |
とう痛及び糖尿病の治療用ナトリウムチャネル調節物質
|
EA032255B1
(ru)
|
2014-03-27 |
2019-04-30 |
Янссен Фармацевтика Нв |
ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 4,5,6,7-ТЕТРАГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИНА И ПРОИЗВОДНЫЕ 5,6,7,8-ТЕТРАГИДРО-4H-ПИРАЗОЛО[1,5-a][1,4]ДИАЗЕПИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Ros1
|
ES2686747T3
(es)
*
|
2014-03-27 |
2018-10-19 |
Janssen Pharmaceutica Nv |
Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirimidina y derivados de 2,3-dihidro-1H-imidazo[1,2-b]pirazol sustituidos como inhibidores de ROS1
|
CN104140427A
(zh)
*
|
2014-07-05 |
2014-11-12 |
湖南华腾制药有限公司 |
一种四氢吡唑并[1,5-a]嘧啶的制备方法
|
JP2017527573A
(ja)
*
|
2014-09-09 |
2017-09-21 |
クロモセル コーポレーション |
糖尿病の治療用の選択的NaV1.7阻害剤
|
KR102384652B1
(ko)
*
|
2015-02-03 |
2022-04-27 |
솔루스첨단소재 주식회사 |
유기 화합물 및 이를 포함하는 유기 전계 발광 소자
|
PE20190761A1
(es)
|
2016-08-31 |
2019-06-05 |
Agios Pharmaceuticals Inc |
Inhibidores de procesos metabolicos celulares
|
EP4069691A1
(en)
|
2019-12-06 |
2022-10-12 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
CN116322544A
(zh)
*
|
2020-08-12 |
2023-06-23 |
云杉生物科学公司 |
用于治疗***的方法和组合物
|
CA3221259A1
(en)
|
2021-06-04 |
2022-12-08 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
|